HHLR Advisors’s Enfusion, Inc. ENFN Stock Holding History

HHLR Advisors’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,975,183	Closed	-$55.5M	–	51
2025 Q1	$55.5M	Hold	4,975,183	–	–	1.57%	13
2024 Q4	$51.2M	Hold	4,975,183	–	–	1.77%	13
2024 Q3	$47.2M	Hold	4,975,183	–	–	1.04%	13
2024 Q2	$42.4M	Hold	4,975,183	–	–	1.05%	12
2024 Q1	$46M	Hold	4,975,183	–	–	1%	15
2023 Q4	$48.3M	Hold	4,975,183	–	–	0.97%	17
2023 Q3	$44.6M	Hold	4,975,183	–	–	1%	15
2023 Q2	$55.8M	Hold	4,975,183	–	–	1.19%	17
2023 Q1	$52.2M	Hold	4,975,183	–	–	0.93%	18
2022 Q4	$48.1M	Hold	4,975,183	–	–	1.02%	18
2022 Q3	$61.4M	Hold	4,975,183	–	–	1.61%	16
2022 Q2	$50.8M	Hold	4,975,183	–	–	1.09%	20
2022 Q1	$63.3M	Hold	4,975,183	–	–	1.32%	19
2021 Q4	$104M	Buy	+4,975,183	New	+$101M	1.61%	13

Other funds holding ENFN

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HHLR Advisors's ENFN Position: Q2 2025 in Review

HHLR Advisors sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 4,975,183 shares — an estimated $55.5M sold.

HHLR Advisors first reported a position in ENFN in Q4 2021 and held it in 14 quarters. The position peaked at $104M in Q4 2021. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

HHLR Advisors reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
HHLR Advisors sold 4,975,183 Enfusion, Inc. shares in Q2 2025, an estimated $55.5M.
HHLR Advisors first reported a position in Enfusion, Inc. in Q4 2021 and held it in 14 quarters.
HHLR Advisors's Enfusion, Inc. position peaked at $104M in Q4 2021.
2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on HHLR Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.